1915

Group B Streptococci Induce Interleukin 8 Production in Human Cervical Epithelial Cell Cultures: The Role of Capsule Polysaccharide

Objective: Group B streptococci (GBS) are the major cause of pneumonia, sepsis, and meningitis in neonates and adults. Epithelial invasion and

Keywords:

Streptococcus Group B, bacterial capsule epithelial cells, IL-8,

PDF

___

[1] Edwards MS, Baker CJ. Streptococcus agalactiae (Group B Streptococcus). Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill, Livingston, Elsevier; 2009;2655–663.
[2] Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11:497-513.
[3] Jones N, Oliver K, Jones Y, Haines A, Crook D. Carriage of group B streptococcus in pregnant women from Oxford, UK. J Clin Pathol 2006; 59:363-66.
[4] Yılmaz Karadağ F, Hızel K, Gelişen O. Colonization of Group B Streptococci In Pregnant Women At Delivery. J Turk Soc Obstet Gynecol 2013; 10:16-20.
[5] Landwehr-Kenzel S, Henneke P. Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease. Front Immunol 2014; 29:519.
[6] Rajagopal L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol 2009; 4:201- 21.
[7] Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 1987; 84:7208-12.
[8] Vornhagen J, Adams Waldorf KM, Rajagopal L. Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies. Trends Microbiol 2017; 25: 919-931.
[9] Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a speciesspecific manner. J Infect Dis 2014; 209:1989-99.
[10] Palomino DC, Marti LC. Chemokines and immunity. Einstein (Sao Paulo) 2015; 13:469-73.
[11] Mukaida N, Harada A, Yasumoto K, Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, Interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 1992; 36:773-89.
[12] Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis 1996; 173: 142-50.
[13] Vallejo JG, Baker CJ, Edwards MS. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J Infect Dis 1996; 174:332-37.
[14] Williams PA, Bohnsack JF, Augustine NH, Drummond WK, Rubens CE, Hill HR. Production of tumor necrosis factor by human cells in vitro and in vivo induced by group B streptococci. J Pediatr 1993; 123:292-300.
[15] Vallejo JG, Baker CJ, Edwards MS. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun 1996; 64:5042-46.
[16] Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med 2008; 22:10:e27.